Arthramid®

@arthramid

Leading the advancement of equine & canine joint health. Arthramid® is a 2.5% injectable iPAAG for the treatment of non-infectious causes of lameness in animals

arthramid.com

Joined December 2024

Arthramid®
@arthramid
Aug 5
The luck of our customers in the West continues! Congratulations to Dr Paul O'Callaghan of Perth Equine Hospital, Western Australia, drawn as the winner of the 2026 VetPD Equine Safari Event Prize Draw. Paul and the team at Perth Equine have supported Arthramid for a long time,
Arthramid®
@arthramid
Jun 11
Join us tonight! Our CE webinar on canine elbow OA is on this evening, with Dr Matt Brunke (DVM, DACVSMR Canine) presenting 12-month safety and efficacy data from the Canine Elbow Study evaluating intra-articular 2.5% iPAAG. Expect a practical session covering study findings,
Arthramid®
@arthramid
May 29
Canine elbow OA is one of the most challenging joints to manage long-term in small animal practice. Multimodal plans help, but the question of where intra-articular therapies fit, and which ones hold up over time, is still an open one for many clinicians. Join us for a CE
Arthramid®
@arthramid
May 28
Last chance to register! Tonight, Dr. Beau Whitaker (Salado Equine Medical Center) and Dr. Sean Allison (Cleveland Equine Clinic) sit down for a RACE-approved CE session on the practical side of using 2.5% iPAAG in equine patients. How much, how often, in which joint, and under
Arthramid®
@arthramid
May 21
Celebrating 1000 Cases! Congratulations to Marty Tanner and Morgan King at @TannerEquine on reaching an extraordinary milestone, 1000 Arthramid® equine injections. This achievement is a testament to their expertise and dedication in helping horses move more freely, perform